C - Chemistry – Metallurgy – 08 – B
Patent
C - Chemistry, Metallurgy
08
B
C08B 37/10 (2006.01) A61K 31/725 (1990.01)
Patent
CA 2084301
The invention relates to new heparin derivatives from bovine or porcine heparin which have a molecular weight equal to or larger than the standard heparin, show a sulfur content which is equal to or higher than that of the starting heparin or at least 13 % w/w, have an anticoagulant activity in the anti-PXa assay of less than 10 % of the standard heparin it was made from, show a ratio of APTT activity over anti-FXa activity of 3-35; show a reduced prolongation of bleeding time compared to the standard heparin it was made from as measured in the rat tail after i.v. administration and show enhancement of the rate of development of coronary collaterals in dogs equal to or better than clinically used heparin. The invention also relates to processes for preparation of the new bovine and porcine heparin derivatives. The use of this product for the manufacturing of a medicament for treatment of ischemic heart disease and related vascular disorders and for the enhancement of the rate of development of coronary collateral perfusion is disclosed.
Mattsson Christer
Svahn Carl-Magnus
Weber Michael
Kabi Pharmacia Aktiebolag
Pfizer Health Ab
Smart & Biggar
LandOfFree
Heparin derivatives and process for the preparation thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heparin derivatives and process for the preparation thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heparin derivatives and process for the preparation thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1635487